0
0 (0%)
Travere Therapeutics, Inc. [RTRX]
Source:
Company Overview
Travere Therapeutics, Inc is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Our approach centers on advancing our innovative pipeline with multiple late-stage clinical programs targeting rare diseases with significant unmet medical needs.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | 888-969-7879 |
| Industry | manufacturing |
| CEO | Eric Dube |
| Website | travere.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $233.2 |
| Operating Profit | $-323.8 |
| Net Income | $-321.5 |
| Net Cash | $0.4 |
Profit Ratios
| Gross Margin | $225.4 |
| Operating Margin | -138.9 |
| Profit as % of Revenues | -70.1% |
| Profit as % of Assets | -46.5% |
| Profit as % of Stockholder Equity | -544.3% |
Management Effectiveness
| Return on Equity | -544.3% |
| Return on Assets | -54.1% |
| Turnover Ratio | 33.7% |
| EBITA | $-323.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $594.1 |
| Total Liabilities | $535 |
| Operating Cash Flow | $-237.5 |
| Investing Cash Flow | $99.3 |
| Financing Cash Flow | $139.4 |
